Possible involvement of dynorphin A release via μ1-opioid receptor on supraspinal antinociception of endomorphin-2

Peptides

Volumn 29, Issue 9, 2008, Pages 1554-1560

  Sakurada, Shinobu ^a   Sawai, Toshiki ^a   Mizoguchi, Hirokazu ^a   Watanabe, Hiroyuki ^a   Watanabe, Chizuko ^a   Yonezawa, Akihiko ^a   Morimoto, Masaya ^b   Sato, Takumi ^c   Komatsu, Takaaki ^d   Sakurada, Tsukasa ^d  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Grelan Pharmaceutical Co   (Japan)

^c NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^d DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Opioid receptor; Antinociception; Dynorphin A; Mouse; Release; Supraspinal

Indexed keywords

BETA FUNALTREXAMINE; DYNORPHIN A; DYNORPHIN B; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONAZINE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOW DRUG DOSE; MALE; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; TAIL FLICK TEST;

ANALGESICS; ANIMALS; DYNORPHINS; ENDORPHINS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; IMMUNE SERA; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NALOXONE; NALTREXONE; OLIGOPEPTIDES; PROTEIN PRECURSORS; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 49049099788     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.04.012     Document Type: Article

References (27)

1. Chapman V., Diaz A., and Dickenson A.H. Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat. Br J Pharmacol 122 (1997) 1537-1539
2. Goldberg I.E., Rossi G.C., Letchworth S.R., Mathis J.P., Ryan-Moro J., Leventhal L., et al. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 286 (1998) 1007-1013
3. Gong J., Strong J.A., Zhang S., Yue X., DeHaven R.N., Daubert J.D., et al. Endomorphins fully activate a cloned human mu opioid receptor. FEBS Lett 439 (1998) 152-156
4. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12 (1957) 12-15
5. Heyman J.S., William C.L., Burk T.F., Mosberg H.I., and Porreca F. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse; studies with naloxonazine. J Pharmacol Exp Ther 245 (1988) 238-243
6. Hosohata K., Burkey T.H., Alfaro-Lopez J., Varga E., Hruby V.J., Roeske W.R., et al. Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor. Eur J Pharmacol 346 (1998) 111-114
7. Leitermann R.J., Terashvili M., Mizoguchi H., Wu H.-E., Chen F., Clithero A., et al. Release of immunoreactive dynorphin A (1-17) from the spinal cord by intrathecal perfusion of endomorphin-2, but not endomorphin-1 in anesthetized rats. Eur J Pharmacol 504 (2004) 177-183
8. Ling G.S.F., Simantov R., Clark J.A., and Pasternak G.W. Naloxonazine action in vivo. Eur J Pharmacol 129 (1986) 33-38
9. Martin-Schild S., Gerall A.A., Kastin A.J., and Zadina J.E. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides 19 (1998) 1783-1789
10. Martin-Schild S., Gerall A.A., Kastin A.J., and Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 405 (1999) 450-471
11. Martin-Schild S., Zadina J.E., Gerall A.A., Vigh S., and Kastin A.J. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18 (1997) 1641-1649
12. 2 opioid binding in the mouse central nervous system. Brain Res 360 (1985) 117-129
13. Narita M., Ozaki S., Ioka M., Mizoguchi H., Nagase H., Tseng L.F., et al. Different motivational effects induced by the endogenous μ-opioid receptor ligands endomorphin-1 and -2 in the mouse. Neuroscience 105 (2001) 213-218
14. Ohsawa M., Mizoguchi H., Narita M., Chiu M., Nagase H., and Tseng L.F. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 294 (2000) 1106-1111
15. Paul D., Bodnar R.J., Gistrak M.A., and Pasternak G.W. Different μ receptor subtypes mediate spinal and supraspinal analgesia in mice. Eur J Pharmacol 168 (1989) 307-314
16. Pick C.C., Paul D., and Pasternak G.W. Comparison of naloxonazine and β-funaltrexamine antagonism of mu 1 and mu 2 opioid actions. Life Sci 48 (1991) 2005-2011
17. Pierce T.L., Grahek M.D., and Wessendorf M.W. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. Neuroreport 9 (1998) 385-389
18. Sakurada S., Hayashi T., Yuhki M., Fujimura T., Murayama K., Yonezawa A., et al. Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methoxynaltrexone. Peptides 23 (2002) 895-901
19. Sakurada S., Hayashi T., Yuhki M., Fujimura T., Murayama K., Yonezawa A., et al. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res 881 (2000) 1-8
20. Sakurada S., Hayashi T., Yuhki M., Orito T., Zadina J.E., Kastin A.J., et al. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol 427 (2001) 203-210
21. Sakurada S., Takeda S., Sato T., Hayashi T., Yuki M., Kutsuwa M., et al. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-β-Ala, a novel dermorphin analogue with high affinity at μ-opioid receptors. Eur J Pharmacol 395 (2000) 107-112
22. Sakurada S., Zadina J.E., Kastin A.J., Katsuyama S., Fujimura T., Murayama K., et al. Differential involvement of μ-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Eur J Pharmacol 372 (1999) 25-30
23. 1-opioid receptors to morphine-induced antinociception. Eur J Pharmacol 369 (1999) 183-187
24. Stone L.S., Fairbanks C.A., Lauglin T.M., Nyuyen H.O., Bushy T.M., Wessendorf M.W., et al. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and endomorphin-2. Neuroreport 8 (1997) 3131-3135
25. Terashvili M., Wu H.E., Leitermann R.J., Hung K.C., Clithero A.D., Schwasinger E.T., et al. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat. J Pharmacol Exp Ther 309 (2004) 816-824
26. Tseng L.F., Narita M., Suganuma C., Mizoguchi H., Ohsawa M., Nagase H., et al. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 292 (2000) 576-583
27. Zadina J.E., Hackler L., Ge L.J., and Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386 (1997) 499-502